Effectiveness of conventional and low-cost wastewater treatments in the removal of pharmaceutically active compounds

Water, Air, and Soil Pollution

Volumn 223, Issue 5, 2012, Pages 2611-2621

  Camacho Munoz D ^a   Martin J ^a   Santos, J L ^a   Aparicio, I ^a   Alonso, E ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Conventional treatment; Low cost treatment; Pharmaceutical compound; Removal rate; Wastewater

Indexed keywords

ACTIVATED SLUDGE; ANTI-INFLAMMATORY DRUGS; ANTIEPILEPTIC DRUGS; CARBAMAZEPINE; CONSTRUCTED WETLANDS; CONVENTIONAL TREATMENTS; EFFICIENCY OF REMOVAL; LAGOONING; LIPID REGULATORS; LOW-COST TREATMENT; NAPROXENS; NERVOUS STIMULANTS; OXIDATION DITCH; PERSISTENT COMPOUNDS; PHARMACEUTICAL COMPOUNDS; PHARMACEUTICALLY ACTIVE COMPOUNDS; REMOVAL RATE; SALICYLIC ACIDS; TRICKLING FILTER; WASTEWATER TREATMENT PLANTS;

ACTIVATED SLUDGE PROCESS; AMIDES; ANTIBIOTICS; COSTS; EFFLUENTS; SEWAGE LAGOONS; WASTEWATER;

RECLAMATION;

AGENTS AFFECTING LIPID METABOLISM; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; ESTROGEN DERIVATIVE; IBUPROFEN; NAPROXEN; PROPRANOLOL; SALICYLIC ACID;

ACTIVATED SLUDGE; ANOXIC CONDITIONS; CONSTRUCTED WETLAND; DRUG; EFFICIENCY MEASUREMENT; EFFLUENT; FILTRATION; MONITORING; OXIDATION; WASTEWATER; WATER TREATMENT;

ACTIVATED SLUDGE; ARTICLE; CONSTRUCTED WETLAND; COST BENEFIT ANALYSIS; DRUG MONITORING; EFFLUENT; LAGOON; OXIDATION; SPAIN; TRICKLING FILTER; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

SPAIN;

EID: 84862162280     PISSN: 00496979     EISSN: 15732932     Source Type: Journal    
DOI: 10.1007/s11270-011-1053-9     Document Type: Article

References (32)

1. APHA. 2005 Standard methods for the examination of water and wastewater (21st ed.). Washington, DC: American Public Health Association.
2. Camacho-Muñoz, D., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2009). An affordable method for the simultaneous determination of the most studied pharmaceutical compounds as wastewater and surface water pollutants. Journal of Separation Science, 32, 3064-3073.
3. Camacho-Muñoz, D., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2010a). Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). Journal of Hazardous Materials, 183, 602-608.
4. Camacho-Muñoz, M. D., Santos, J. L., Aparicio, I., & Alonso, E. (2010b). Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. Journal of Hazardous Materials, 177, 1159-1162.
5. Conkle, J. L., White, J. R., & Metcalfe, C. D. (2008). Reduction of pharmaceutically active compounds by lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere, 73, 1741-1748.
6. Díaz-Cruz, M., López de Alda, M. J., & Barceló, D. (2003). Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends in Analytical Chemistry, 22, 340-351.
7. Dordio, A., Palace, A. J., Martins, D., Barrocas, C., & Pinto, A. P. (2010). Removal of pharmaceuticals in microcosm constructed wetlands using Typha spp. and LECA. Bioresource Technology, 101, 886-892.
8. Farré, M., Ferrer, I., Ginebreda, A., Figueras, M., Olivella, L., Tirapu, L., Vilanova, M., & Barceló, D. (2001). Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. Journal of Chromatography. A, 938, 187-197.
9. García, J., Rousseau, D. P. L., Morató, J., Lesage, E., Matamoros, V., & Bayona, J. M. (2010). Contaminant removal processes in subsurface-flow constructed wetlands: a review. Critical Reviews in Environmental Science and Technology, 40, 561-661.
10. Göbel, A., McArdell, C. S., Joss, A., Siegrist, H., & Giger, W. (2007). Fate of sulfonamides, macrolides, and trimethorprim in different wastewater treatment technologies. Science of the Total Environment, 372, 361-371.
11. Hashimoto, T., Onda, K., Nakamura, Y., Tada, K., Miya, A., & Murakami, T. (2007). Comparison of natural estrogen removal efficiency in the conventional activated sludge process and the oxidation ditch process. Water Research, 41, 2117-2126.
12. Hijosa-Valsero,M., Matamoros, V., Martín-Villacorta, J., Bécares, E.,& Bayona, J.M. (2010a). Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Research, 44, 1429-1439.
13. Hijosa-Valsero, M., Matamoros, V., Sidrach-Cardona, R., Martín- Villacorta, J., Bécares, E., & Bayona, J. M. (2010b). Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters. Water Research, 44, 3669-3678.
14. Jones, O. A. H., Voulvoulis, N., & Lester, J. N. (2007). The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environmental Pollution, 145, 738-744.
15. Kasprzyk-Hordern, B., Dinsdale, R. M., & Guwy, A. J. (2008). The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research, 42, 3498-3518.
16. Kasprzyk-Hordern, B., Dinsdale, R. M., & Guwy, A. J. (2009). The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research, 43, 363-380.
17. Lacey, C., McMahon, G., Bones, J., Barron, L., Morrisey, A., & Tobin, J. M. (2008). An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples. Talanta, 75, 1089-1097.
18. Lajeunesse, A., & Gagnon, C. (2007). Determination of acidic pharmaceutical products and carbamazepine in roughly primary-treated wastewater by solid-phase extraction and gas chromatography-tandem mass spectrometry. International Journal of Environmental Analytical Chemistry, 87, 565-578.
19. Lindqvist, N., Tuhkanen, T., & Kronberg, L. (2005). Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research, 39, 2219-2228.
20. Matamoros, V., Puigagut, J., García, J., & Bayona, J. M. (2007). Behavior of selected priority organic pollutants in horizontal subsurface flow constructed wetlands: a preliminary screening. Chemosphere, 69, 1374-1380.
21. Matamoros, V., Hijosa, M., & Bayona, J. M. (2009). Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere, 75, 200-205.
22. Radjenović, J., Petrović, M., & Barceló, D. (2009). Complementary mass spectrometry and bioassays for evaluating pharmaceutical-transformation products in treatment of drinking water and wastewater. Trends in Analytical Chemistry, 28, 562-580.
23. Rauch-Williams, T., Hoppe-Jones, C., & Drewes, J. E. (2010). The role of organic matter in the removal of emerging trace organic chemicals during managed aquifer recharge. Water Research, 44, 449-460.
24. Santos, J. L., Aparicio, I., Alonso, E., & Callejón, M. (2005). Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors. Analytica Chimica Acta, 550, 116-122.
25. Santos, J. L., Aparicio, I., Callejón, M., & Alonso, E. (2008). Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). Journal of Hazardous Materials, 164, 1509-1516.
26. Sui, Q., Huang, J., Deng, S., Yu, G., & Fan, Q. (2010). Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Research, 44, 417-426.
27. Tauxe-Wuersch, A., De Alencastro, L. F., Grandjean, D., & Tarradellas, J. (2005). Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Research, 39, 1761-1772.
28. Ternes, T., Bonerz, M., & Schmidt, T. (2001). Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography- electrospray tandem mass spectrometry. Journal of Chromatography. A, 938, 175-185.
29. Ternes, T., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H., Haist-Gulde, B., Preuss, G., Wilme, U., & Zulei-Seibert, N. (2002). Removal of pharmaceuticals during drinking water treatment. Environmental Science and Technology, 36, 3855-3863.
30. Tsoumanis, C. M., Giokas, D. L., & Vlessidis, G. (2010). Monitoring and classification of wastewater quality using supervised pattern recognition techniques and deterministic resolution of molecular absorption spectra based on multiwavelenght UV spectra deconvolution. Talanta, 82, 575-581.
31. Vieno, N., Tuhkanen, T., & Kronberg, L. (2007). Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Research, 41, 1001-1012.
32. Zorita, S., Martensson, L., & Mathiasson, L. (2009). Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Science of the Total Environment, 407, 2760-2770.